Navigation Links
Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
Date:8/9/2011

ARDEN HILLS, Minnesota, August 9, 2011 /PRNewswire/ --

 

- Cryotherapy Continues to Grow as the Treatment of Choice for Renal Tumors Around the World

Galil Medical, a global leader in minimally invasive cryotherapy treatments, announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for small renal cancer cryoablation using a percutaneous approach, as well as under open or endoscopic surgery.

 "We appreciate the MHLW reimbursement decision as this will allow Japanese patients to have greater access to renal cryoablation and benefit from Galil's advanced technology," commented Martin Emerson, Galil Medical President and CEO.

Galil Medical's CryoHit/SeedNet for MRI received approval for small renal tumor cryoablation under MRI-guidance in January 2010 from the MHLW. The regulatory and reimbursement approval processes have been spearheaded by Hitachi Medical Corporation, Galil Medical's exclusive distribution partner in Japan.

Cryotherapy is a minimally invasive procedure that uses extreme cold to freeze and destroy tumors. Visualization with MR imaging monitors the ablation zone of the tumor and minimizes impact to healthy adjacent tissue.

Standard treatment options for renal cancer include total and partial nephrectomy, open and laparoscopic procedures.  Minimally invasive ablative therapies, such as percutaneous cryotherapy, are increasingly accepted treatment options due to favorable clinical outcomes, reduced procedural pain, fewer complications and faster patient recovery. 

About Galil Medical Galil Medical is a global leader in delivering innovative cryotherapy solutions. The company is addressing patient conditions across multiple physician specialties; treatment areas include conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. Company offices are located in Arden Hills, Minnesota; Yokneam, Israel; and London, United Kingdom. Shareholders include Thomas, McNerney & Partners, The Vertical Group, and Investor Growth Capital.

Contact information:

Pam Schwartz
Asia Pacific Manager
Galil Medical
T: +972-4-909-3273
M: +972-52-625-4443
F: +972-4-959-1077
pam.schwartz@galilmedical.com

Lisa Hayden
Vice President, Global Reimbursement
Galil Medical
T: +1-877-639-2796 option #4
M: +1-703-209-7774
F: +1-651-287-5125
lisa.hayden@galilmedical.com



'/>"/>
SOURCE Galil Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN
2. Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
3. Healthcare Practices Considering Outsourcing Their Medical Typing Requirements - Med Data Care Pro, an Ideal Choice
4. Carrot Medical Positioned for Third Straight Year of Triple Digit Growth
5. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
6. Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey
7. Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
8. China Medical Technologies and Leica Microsystems Announce Collaboration
9. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
10. South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems
11. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):